Biomarker commercialisation project approved

27-05-2017

The goal of the project is to increase the commercial potential of biomarker discoveries in the Baltic Sea Region

Biomarker commercialisation project approved

Ideklinikken at Aalborg University Hospital, the University of Turku, Finland, The University of Vilnius, Lithuania, and the 6 innovation clusters Biopeople (Denmark), BioCon Valley (Germany), Turku Science Park (Finland), Tartu Biotechnology Park (Estonia), Wroclaw Technology Park (Poland) and ScanBalt covering the Baltic Sea Region earlier this year applied for an interregional project related to the commercialisation of biomarkers (BiC). The project will create and stimulate synergies between industry, cluster organisations and research institutions across the Baltic Sea Region.

“The project consortium intend to involve industry earlier in the development and commercialization process of biomarkers and develop tools providing guidance to research institutions when selecting the most relevant biomarker discoveries and conduct a development plan that meets early requirements from industry,” says Kjeld Lisbye, Head of Innovation in the Northern Region of Denmark. “We want to define the downstream pathway from research, validation, development to the market, co-created with industry in order to speed up the process and create successful spinouts.”

The BiC project will focus on the development of the below tools which will be available via Scanbalt Business Club beyond the project period:

  • a Biomarker Development Tool
  • a Screening and Selection Guide
  • a Framework for Technology Translation into clinical setting
  • Business Model Templates
  • BSR Biomarker Platform, Technology presentation and match making tools

Related

What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.